Biolife Solutions (BLFS) Invested Capital (2019 - 2026)

Biolife Solutions (BLFS) has reported Invested Capital for 8 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Invested Capital fell 76.08% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $25.0 million (up 4.59% YoY), while the FY2025 annual figure was $5.0 million, down 54.34% from the prior year.
• Invested Capital retreated to $2.5 million in Q1 2026 per BLFS's latest filing, from $5.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $10.9 million in Q4 2024 and bottomed at $256000.0 in Q1 2023.
• Historically, Invested Capital has averaged $3.4 million across 5 years, with a median of $1.5 million in 2023.
• Annual changes were most pronounced in 2025 — Invested Capital jumped 665.5% — and 2026, when it slumped 76.08%.
• Biolife Solutions' Invested Capital stood at $284000.0 in 2022, then surged by 444.01% to $1.5 million in 2023, then surged by 608.28% to $10.9 million in 2024, then sank by 54.34% to $5.0 million in 2025, then plunged by 49.99% to $2.5 million in 2026.
• Business Quant data shows BLFS's Invested Capital at $2.5 million in Q1 2026, $5.0 million in Q4 2025, and $7.5 million in Q3 2025.